Brain Disease Modalities and Software Market Size to Reach USD 27.72 billion by 2033 | Straits Research
Straits Research is pleased to announce the release of its latest market report on the global Brain Disease Modalities and Software Market. The report provides an in-depth analysis of market size, segmentation, growth factors, opportunities, and key players, offering valuable insights for stakeholders and industry participants.
Market Size and Growth
The global brain disease modalities and software market size was valued at USD 15.73 billion in 2024 and is projected to reach from USD 16.75 billion in 2025 to USD 27.72 billion by 2033, growing at a CAGR of 6.50% during the forecast period (2025-2033).
Request a Free Sample (Free Executive Summary at Full Report Starting from USD 1850): https://straitsresearch.com/report/brain-disease-modalities-and-software-market/request-sample
Market Definition and Latest Trends
The Brain Disease Modalities and Software Market encompasses a range of technologies and software solutions designed to diagnose, monitor, and treat various brain diseases. Key modalities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and hybrid imaging techniques that combine PET with MRI or CT. Advanced MRI techniques such as diffusion tensor imaging (DTI), diffusion-weighted imaging (DWI), susceptibility-weighted imaging (SWI), and dynamic susceptibility contrast (DSC) imaging are gaining traction, particularly in North America and Europe
Recent trends in the market include the integration of artificial intelligence (AI) in medical imaging, which enhances the accuracy and efficiency of diagnostic processes. Additionally, there is a growing preference for non-invasive imaging techniques that minimize patient discomfort and exposure to radiation.
Market Segmentation with Insights-Driven Strategy Guide: https://straitsresearch.com/report/brain-disease-modalities-and-software-market/segmentation
Market Segmentation
The report segments the Brain Disease Modalities and Software Market based on offering, patient type, application, and end user:
Based on Offering
- Brain Imaging Modalities
- Brain Analysis Software
Based on Patient Type
- Adult
- Paediatrics Infants
Based on Application
- Traumatic Brain Injury (TBI)
- Headache Disorders
- Epilepsy
- Sleep Disorders
- Parkinson's Disease
- Stroke
- Huntington's Disease
- Dementia
Based on End User
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Diagnostic Imaging Centers
Buy Full Report (Exclusive Insights with In-Depth Data Supplement): https://straitsresearch.com/buy-now/brain-disease-modalities-and-software-market
Growth Factors and Opportunities
The increasing incidence of neurological disorders such as Alzheimer's disease, epilepsy, Parkinson's disease, and stroke is a major driver of market growth. The rising demand for advanced imaging techniques and the integration of AI in diagnostic tools present significant opportunities for market expansion
Key Players
The report highlights the key players in the Brain Disease Modalities and Software Market, including:
- Koninklijke Philips N.V.
- General Electric Company
- Canon Inc.
- Siemens Healthineers AG
- Vuno Co. Ltd.
- Fujifilm Holdings Corporation
- Imaging Biometrics LLC
- I. Analysis Inc.
- Aspect Imaging Ltd.
- Subtle Medical Inc.
- IXICO plc
- Mint Labs Inc.
Table of Contents for the Brain Disease Modalities and Software Market Report: https://straitsresearch.com/report/brain-disease-modalities-and-software-market/toc
These companies are at the forefront of innovation, continuously developing new technologies and solutions to improve the diagnosis and treatment of brain diseases.
Conclusion
Straits Research's comprehensive report on the Brain Disease Modalities and Software Market provides valuable insights into the current market landscape and future growth prospects. With detailed analysis and segmentation, the report serves as an essential resource for industry stakeholders, helping them make informed decisions and capitalize on emerging opportunities.
Contact Us:
- Email:sales@straitsresearch.com
- Address: 825 3rd Avenue, New York, NY, USA, 10022
- Phone: +1 646 905 0080 (U.S.) | +91 8087085354 (India) | +44 203 695 0070 (U.K.)
